Published in Eur Urol on October 07, 2008
Perioperative morbidity of radical cystectomy: A review. Indian J Urol (2011) 0.84
Comparison of surgical technique (open vs. laparoscopic) on pathological and long term functional outcomes following radical prostatectomy. BMC Urol (2014) 0.76
Editorial comment on: Laparoscopy in German urology: changing acceptance among urologists. Eur Urol (2008) 0.75
Preliminary experience with radical cystectomy and w-ileal pouch for muscle invasive transitional cell bladder carcinoma. J West Afr Coll Surg (2012) 0.75
Minilaparoscopy in urology: initial results after 32 cases. World J Urol (2015) 0.75
Development of urologic laparoscopy in Germany, Austria, and Switzerland: a survey among urologists. World J Urol (2014) 0.75
Retropubic, laparoscopic, and robot-assisted radical prostatectomy: a systematic review and cumulative analysis of comparative studies. Eur Urol (2009) 4.58
Downsides of robot-assisted laparoscopic radical prostatectomy: limitations and complications. Eur Urol (2009) 2.76
Age and bladder outlet obstruction are independently associated with detrusor overactivity in patients with benign prostatic hyperplasia. Eur Urol (2008) 2.52
Robotic-assisted laparoscopic extended pelvic lymph node dissection for prostate cancer: surgical technique and experience with the first 99 cases. Eur Urol (2008) 2.42
Laparoendoscopic single-site and natural orifice transluminal endoscopic surgery in urology: a critical analysis of the literature. Eur Urol (2010) 2.28
A new postoperative predictor of time to urinary continence after laparoscopic radical prostatectomy: the urine loss ratio. Eur Urol (2006) 2.22
Topographical anatomy of periprostatic and capsular nerves: quantification and computerised planimetry. Eur Urol (2008) 2.22
Nerve quantification and computerized planimetry to evaluate periprostatic nerve distribution-does size matter? Urology (2009) 2.14
Diagnostic accuracy of noninvasive tests to evaluate bladder outlet obstruction in men: detrusor wall thickness, uroflowmetry, postvoid residual urine, and prostate volume. Eur Urol (2006) 2.05
Photoselective vaporization (PVP) versus transurethral resection of the prostate (TURP): a prospective bi-centre study of perioperative morbidity and early functional outcome. Eur Urol (2005) 2.03
Is there a role for tamsulosin in the treatment of distal ureteral stones of 7 mm or less? Results of a randomised, double-blind, placebo-controlled trial. Eur Urol (2009) 1.87
Pelvic lymph node dissection during robot-assisted radical prostatectomy: efficacy, limitations, and complications-a systematic review of the literature. Eur Urol (2013) 1.69
Laser fibre deterioration and loss of power output during photo-selective 80-w potassium-titanyl-phosphate laser vaporisation of the prostate. Eur Urol (2008) 1.62
Endoscopic extraperitoneal radical prostatectomy: oncological and functional results after 700 procedures. J Urol (2005) 1.61
Update on phosphodiesterase (PDE) isoenzymes as pharmacologic targets in urology: present and future. Eur Urol (2006) 1.61
Combined magnetic resonance imaging and magnetic resonance spectroscopy imaging in the diagnosis of prostate cancer: a systematic review and meta-analysis. Eur Urol (2008) 1.60
Life-threatening complication after right renal extracorporeal shock wave lithotripsy: large hepatic haematoma requiring embolisation of the right hepatic artery. Eur Urol (2007) 1.57
Three-dimensional vs standard laparoscopy: comparative assessment using a validated program for laparoscopic urologic skills. Urology (2013) 1.56
Intermediate-term results of retroperitoneoscopy-assisted cryotherapy for small renal tumours using multiple ultrathin cryoprobes. Eur Urol (2006) 1.53
Intrafascial nerve-sparing endoscopic extraperitoneal radical prostatectomy. Eur Urol (2007) 1.53
Sexual function after transurethral resection of the prostate (TURP): results of an independent prospective multicentre assessment of outcome. Eur Urol (2007) 1.52
Beta-catenin-related anomalies in apoptosis-resistant and hormone-refractory prostate cancer cells. Clin Cancer Res (2003) 1.52
Urological surgery and antiplatelet drugs after cardiac and cerebrovascular accidents. J Urol (2010) 1.52
High power (80 W) potassium-titanyl-phosphate laser vaporization of the prostate in 66 high risk patients. J Urol (2005) 1.51
Safety and effectiveness of photoselective vaporization of the prostate (PVP) in patients on ongoing oral anticoagulation. Eur Urol (2006) 1.50
A comparison of outcomes for interfascial and intrafascial nerve-sparing radical prostatectomy. Urology (2010) 1.50
Increase in detrusor wall thickness indicates bladder outlet obstruction (BOO) in men. World J Urol (2002) 1.48
Collecting system percutaneous access using real-time tracking sensors: first pig model in vivo experience. J Urol (2013) 1.48
RevoLix vaporesection of the prostate: initial results of 54 patients with a 1-year follow-up. World J Urol (2007) 1.48
The role of 11C-choline and 18F-fluorocholine positron emission tomography (PET) and PET/CT in prostate cancer: a systematic review and meta-analysis. Eur Urol (2013) 1.47
Immunohistochemical distribution of cyclic GMP-dependent protein kinase-1 in human prostate tissue. Eur Urol (2007) 1.46
Is type 2 diabetes mellitus a predictive factor for incontinence after laparoscopic radical prostatectomy? A matched pair and multivariate analysis. J Urol (2010) 1.46
Dual-energy computed tomography for the differentiation of uric acid stones: ex vivo performance evaluation. Urol Res (2008) 1.45
Lateral temperature spread of monopolar, bipolar and ultrasonic instruments for robot-assisted laparoscopic surgery. BJU Int (2014) 1.44
Direct comparison of the different conventional laparoscopic positions with the ethos surgical platform in a laparoscopic pelvic surgery simulation setting. J Endourol (2015) 1.41
Retroperitoneoscopic living donor nephrectomy: a retrospective comparison to the open approach. Transplantation (2004) 1.39
Laparoscopic radical prostatectomy in the UK: defining and overcoming the obstacles. BJU Int (2007) 1.39
KPNA2 expression is an independent adverse predictor of biochemical recurrence after radical prostatectomy. Clin Cancer Res (2011) 1.38
Is kidney surgery going to be minimally invasive in all cases? Eur Urol (2007) 1.38
Long-term experience with surgical and conservative treatment of penile fracture. J Urol (2004) 1.37
The learning curve for laparoscopic radical prostatectomy: an international multicenter study. J Urol (2010) 1.30
Loss of PBRM1 expression is associated with renal cell carcinoma progression. Int J Cancer (2012) 1.27
Experimental comparison of high power (80 W) potassium titanyl phosphate laser vaporization and transurethral resection of the prostate. J Urol (2004) 1.18
Three-dimensional laparoscopic imaging improves surgical performance on standardized ex-vivo laparoscopic tasks. J Endourol (2012) 1.17
Multi-target fluorescence in situ hybridization in bladder washings for prediction of recurrent bladder cancer. Int J Cancer (2006) 1.15
Inhibition of p53 function diminishes androgen receptor-mediated signaling in prostate cancer cell lines. Oncogene (2004) 1.15
Nerve sparing endoscopic extraperitoneal radical prostatectomy--effect of puboprostatic ligament preservation on early continence and positive margins. Eur Urol (2005) 1.15
Laparoscopic radical prostatectomy--the experience of the German Laparoscopic Working Group. Eur Urol (2005) 1.14
Photoselective vaporization of the prostate: the basel experience after 108 procedures. Eur Urol (2005) 1.12
Acute hypoxia increases the aggressive characteristics and survival properties of prostate cancer cells. Prostate (2003) 1.12
Engineering functional bladder tissues. J Tissue Eng Regen Med (2012) 1.10
Modular training for residents with no prior experience with open pelvic surgery in endoscopic extraperitoneal radical prostatectomy. Eur Urol (2005) 1.10
Reassessing the current UICC/AJCC TNM staging for renal cell carcinoma. Eur Urol (2009) 1.07
Ultrasound measurement of detrusor wall thickness in healthy adults. Neurourol Urodyn (2006) 1.07
Mining tissue microarray data to uncover combinations of biomarker expression patterns that improve intermediate staging and grading of clear cell renal cell cancer. Clin Cancer Res (2009) 1.06
RASSF1A promoter methylation and expression analysis in normal and neoplastic kidney indicates a role in early tumorigenesis. Mol Cancer (2007) 1.06
VHL gene mutations and their effects on hypoxia inducible factor HIFα: identification of potential driver and passenger mutations. Cancer Res (2011) 1.05
Immunohistochemical distribution of cAMP- and cGMP-phosphodiesterase (PDE) isoenzymes in the human prostate. Eur Urol (2006) 1.05
MR-sequences for prostate cancer diagnostics: validation based on the PI-RADS scoring system and targeted MR-guided in-bore biopsy. Eur Radiol (2014) 1.04
Long-term results of interstitial brachytherapy (LDR-Brachytherapy) in the treatment of patients with prostate cancer. World J Urol (2006) 1.03
Current status of laparoendoscopic single-site surgery in urology. World J Urol (2009) 1.01
Chyloretroperitoneum with secondary chylothorax after retroperitoneoscopic donor nephrectomy. Urology (2005) 1.01
Endoscopic extraperitoneal radical prostatectomy: the University of Leipzig experience of 2000 cases. J Endourol (2008) 1.01
Reduction in incidence of lymphocele following extraperitoneal radical prostatectomy and pelvic lymph node dissection by bilateral peritoneal fenestration. World J Urol (2008) 1.01
The prognostic value of cytology and fluorescence in situ hybridization in the follow-up of nonmuscle-invasive bladder cancer after intravesical Bacillus Calmette-Guérin therapy. Int J Cancer (2009) 1.00
The radius surgical system - a new device for complex minimally invasive procedures in urology? Eur Urol (2006) 1.00
The effect of previous transperitoneal laparoscopic inguinal herniorrhaphy on transperitoneal laparoscopic radical prostatectomy. J Urol (2005) 0.99
Painful leg: a very unusual presentation of renal cell carcinoma. Case report and review of the literature. Urol Int (2009) 0.99
The emergence of protocadherin-PC expression during the acquisition of apoptosis-resistance by prostate cancer cells. Oncogene (2002) 0.98
Endoscopic extraperitoneal radical prostatectomy in patients with prostate cancer and previous laparoscopic inguinal mesh placement for hernia repair. World J Urol (2005) 0.98
Urinary tract injuries in patients with multiple trauma. World J Urol (2007) 0.98
Effects of phosphodiesterase inhibitors on tension induced by norepinephrine and accumulation of cyclic nucleotides in isolated human prostatic tissue. Urology (2008) 0.98
Augmented reality: a new tool to improve surgical accuracy during laparoscopic partial nephrectomy? Preliminary in vitro and in vivo results. Eur Urol (2009) 0.98
MAGE-C2/CT10 protein expression is an independent predictor of recurrence in prostate cancer. PLoS One (2011) 0.97
Technical aspects of lasers in urology. World J Urol (2007) 0.96
Computed tomography perfusion imaging of renal cell carcinoma: systematic comparison with histopathological angiogenic and prognostic markers. Invest Radiol (2013) 0.96
Biological vascularized matrix for bladder tissue engineering: matrix preparation, reseeding technique and short-term implantation in a porcine model. J Urol (2005) 0.96
Comparison of transperitoneal and extraperitoneal laparoscopic radical prostatectomy using match-pair analysis. Eur Urol (2004) 0.95
Robotic suturing: technique and benefit in advanced laparoscopic surgery. Minim Invasive Ther Allied Technol (2008) 0.95
Urine detection of survivin is a sensitive marker for the noninvasive diagnosis of bladder cancer. J Urol (2004) 0.95
Alteration of subcellular and cellular expression patterns of cyclin B1 in renal cell carcinoma is significantly related to clinical progression and survival of patients. Int J Cancer (2006) 0.95
Impact of previous surgery on endoscopic extraperitoneal radical prostatectomy. Urology (2005) 0.95
Prevention and management of perioperative complications in laparoscopic and endoscopic radical prostatectomy. World J Urol (2008) 0.94
Transurethral resection for bladder cancer using 5-aminolevulinic acid induced fluorescence endoscopy versus white light endoscopy. J Urol (2002) 0.93
Intrafascial nerve-sparing endoscopic extraperitoneal radical prostatectomy. Urology (2006) 0.93
The nitric oxide pathway in the human prostate: clinical implications in men with lower urinary tract symptoms. World J Urol (2008) 0.93
Delayed infection of a pelvic lymphocele following robotic radical prostatectomy and pelvic lymphadenectomy: two cases. Urol Int (2009) 0.93
Laparoscopic ureteral reimplantation: prospective evaluation of medium-term results and current developments. World J Urol (2009) 0.93
Prospective evaluation of irrigation fluid absorption during pure transurethral bipolar plasma vaporisation of the prostate using expired-breath ethanol measurements. BJU Int (2013) 0.92
Laparoscopic retroperitoneal lymph node dissection combined with adjuvant chemotherapy for pathological stage II disease in nonseminomatous germ cell tumours: a 15-year experience. BJU Int (2008) 0.91
What information are urologists extracting from prostate needle biopsy reports and what do they need for clinical management of prostate cancer? Eur Urol (2005) 0.91
Endoscopic extraperitoneal radical prostatectomy after previous transurethral resection of prostate: oncologic and functional outcomes of 100 cases. Urology (2009) 0.91